Welcome to the GHAPP Digital Hub

The Gastroenterology & Hepatology Advanced Practice Providers (GHAPP) is dedicated to developing educational programs, providing professional advancement services, and assembling resources for—and guided by—advanced practice providers (APPs). The GHAPP Digital Hub is the place for all GI & Liver digital education for APPs. Here you will have access to podcasts and various short video modules.

bannershape

bgdots

bannershape

sectionimg

Faculty

Janet Gripshover

CRNP

Wilkes-Barre, PA, USA

Erin Darguzas

NP

Chicago, IL, USA

Sherona Bau

NP

Los Angeles, CA, USA

Peter Byrne

FNP

Denver, CO, USA

Jamie Brogan

NP

Chicago, IL, USA

Andrea Banty

NP

Los Angeles, CA, USA

Sarah Enslin

PA-C

Rochester, NY, USA

Shayla Schoenoff

PA-C

Rochester, MN, USA

Amy Stewart

CRNP

Washington D.C., DC, USA

Alison Krustapentus

NP-C

Boston, MA, USA

Erica Heagy

RN, MSN, FNP

Alaska Digestive & Liver Disease

Kate Scarlata

MPH, RD

Medway, Massachusetts

Daksesh Patel

D.O

St. Francis Hospital

Kaitlin Colella

PA

Orlando Health Digestive Health Institute

Andrea Gossard

APRN, CNP

Rochester, MN

Lindsay Yoder

MPAS, PA-C

Indianapolis, Indiana

Lucy Mathew

NP, MSN

Los Angeles, California

Allison Moser

FNP-BC

Chicago, IL

Jeremy Davis

ACNP

Shreveport, LA

Jordan Mayberry

PA-C

UT Southwestern Medical Center

Podcasts

KOL Interview: Can You Discuss Any Recent Breakthroughs in the Management of Cirrhosis?

GHAPPcast Part 3: Provider & Patient Support

GHAPPcast Part 2: Diagnosis and Management

GHAPPcast Part 1: Understanding Chronic Liver Disease and Cirrhosis

GHAPPcast: CD64+ Binding: Description, Relevance, and Potential Clinical Implications

GHAPPcast: The IL23/IL17 Cascade and Implications in the Pathogenesis of IBD

GHAPPcast: CSID in Adults: Clinical Pearls & the Patient Journey

GHAPP PBC Podcast Series Part 3: The Key Highlights of PBC at the GHAPP Conference 2024

GHAPP PBC Podcast Series Part 2: New Therapeutics In The PBC Space

GHAPP PBC Podcast Series Part 1: Prevalence, Awareness and Identification of PBC

KOL Conversation: A New Treatment Option

KOL Conversation: New & Emerging Treatment Considerations for PBC & PBC Pruritus

GHAPPcast: Recognizing the Severity of MASH

GHAPPcast: Navigating IBS: Pathophysiology, Neuromodulators, and Patient-Centered Care

GHAPP/CLDF Podcast: Cirrhosis and Hepatic Encephalopathy

GHAPPcast: Biosimilars and the Patient Perspective

Mastering IBS-C: Diagnostic Strategies, Differentiation, and Management.

Biosimilars Unveiled: Empowering APPs for Better Patient Conversations

Webcasts

Hot Topics in Chronic Liver Disease and Gi Disorders

Defining, Diagnosing, & Treating MASH

Lifestyle Modifications for Patients With MASH

Treatment of Metabolic Disorders and the Role of APPs in MASH

Updates On Approved Treatments for MASH

MASH Bootcamp Q&A

Identifying & Diagnosing MASH Patients with Non-Invasive Tests

2024 IBD Bootcamp

PBC New Therapeutic

FAQ Video Modules

What Should Patients Know About Living With Cirrhosis?

What Are Predictive Risk Factors for Disease Severity in CD and UC?

What Lifestyle Changes Are Essential for Managing Cirrhosis Effectively?

How Can You Support a Shared Decision Making Process With the Patient?

How Can Physicians Better Care for Patients With Cirrhosis?

Is There a Correlation Between Myeloid Cells Expressing CD64 and Endoscopic Disease Severity?

Why Is Binding CD64+ Important When Discussing IL-23 Directed Therapy?

Provide Immunologic Rationale for IL-23 Directed Therapy in IBD

What Is the Role of the IL-23/IL-17 Axis in IBD?

Describe the IL-23/IL-17 Axis

Define, Compare, and Contrast Humoral and Cell-Mediated Immunity

How Is MASH Severity Staged? What Would an Ideal MASH NIT Algorithm Look Like?

What Are the Consequences of MASH Going Untreated?

What is MASH?

What Does It Mean for a Biosimilar to Be Interchangeable, and Why Is That Important?

What Resources Do You Use to Understand the Latest Approaches to Managing IBS-C Patients?

Best Practices to Accelerate the Time to Finding the Right Therapy for Your Patients With IBS-C?

Best Practices in Determining Clinically Meaningful “Response” to Therapy for IBS-C Patients?

What is the Difference Between Biosimilars and Generics?

What Role Does a New Mechanism of Action Play in Your Prescribing Decisions for IBS-C Therapy?

Journal Club Video Modules

Guselkumab Efficacy & Safety in Moderate to Severe CD-GALAXI 2 & 3 Results

Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study

Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis

A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

Medication Review Video Modules

What Are Guselkumab's Other FDA Indications and How Might That Affect Patient Care?

What Is the Efficacy of Guselkumab in Ulcerative Colitis and Crohn's Disease?

What Is the Safety Profile of Guselkumab in Ulcerative Colitis and Crohn's Disease?

How Is Guselkumab Dosed in IBD?

What Is Non-Responder Imputation and How Is It Utilized in Clinical Trials?

Describe the Mechanism of Action of Guselkumab

What Is Resmetirom and How Does It Work to Treat MASH?

What Is the Clinical Profile of Resmetirom, Including Dosing Schedules?

Publications

Comparative Efficacy of Glucagon-Like Peptide 1 Receptor Agonists for Cardiovascular Outcomes in Asian Versus White Populations: Systematic Review and Meta-analysis of Randomized Trials of Populations With or Without Type 2 Diabetes and/or Overweight or Obesity

Diagnostic yield of endoscopic ultrasound-guided fine-needle aspiration-based cytology for distinguishing malignant and benign pancreatic cystic lesions: A systematic review and meta-analysis

Seroprevalence and associated factors for hepatitis B and hepatitis C viral infection among patients with diabetes mellitus in Northern Tanzania

A novel model for identifying infections in patients with acute-on-chronic liver disease (AoCLD): A nationwide, multicenter, prospective cohort study

Alveolar echinococcosis in the canton of Geneva between 2010 and 2021: a descriptive analysis

Yes-associated protein (YAP) plays oncogenic roles in human sporadic colorectal adenomas

Post-esophagectomy aortogastric-tube fistula treated successfully with TEVAR: case report and review of the literature

Protocol for AI-based segmentation and quantification of interstitial cells of Cajal in murine gastric muscle

Novel Transcriptomic Signatures in Fibrostenotic Crohn's Disease: Dysregulated Pathways, Promising Biomarkers, and Putative Therapeutic Targets

Protocol and Study Population of a Prospective Study of Patients With Chronic Pancreatitis and Exocrine Pancreatic Insufficiency: Preliminary Findings From the PACT-CP Registry Show Reduced Health-Related Quality of Life

Duodenal Laser Ablation for Treatment of Type 2 Diabetes: Results of First in Human Study

Can You Cannulate? Contrasting Two Methods and Hardwiring Success

An Education Intervention in Gastrointestinal Healthcare Workers Improves Knowledge of Sexual and Gender Minority Digestive Health

Targeting both the enzymatic and non-enzymatic functions of DHODH as a therapeutic vulnerability in c-Myc-driven cancer

Association Between Smoking Status and Prevalence of Advanced Outcomes in Patients With and Without Positive Stool Test Prior to Colonoscopy: Data from the New Hampshire Colonoscopy Registry

Interleukin-6 single gene polymorphism in patients with inflammatory bowel diseases

Pharyngeal Electrical Stimulation favorably modifies healthy human pharyngo-esophageal function - a randomized trial using High Resolution Manometry Impedance

Vascular Smooth Muscle Cell TG2 Promotes DOCA/Salt-Induced Arterial Stiffness and Hypertension

Health-related quality of life is impaired in people with autoimmune hepatitis: Results of a multicentre cross-sectional study within the European Reference Network

Lipodystrophy Severity Score to Assess Disease Burden in Lipodystrophy

sectionimg

dotimg

Download the app and start using it now

Download on the App Store

GET IT ON Google Play